RxDoctor Payments Data

Nathan Young, DPM

Foot & Ankle Surgery · Roanoke, VANPI 1841425600

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Musculoskeletal Transplant Foundation Inc. accounts for 60.7% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $5,850 and has fallen 95.8% since, to $247 in 2025.

$8,822in general payments, 2019–2025

Across 53 payments — averaging $166.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Musculoskeletal Transplant Foundation Inc.$5K
  • Johnson & Johnson$1K
  • Stryker$1K
  • Polarityte, Inc.$160
  • Nevro Corp.$149
  • Kerecis Limited$99
  • plus $433 from 11 others
$44,505in research payments, 2019–2025

Across 16 payments — averaging $2781.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Polarityte, Inc.$29K
  • Ipsen Innovation$15K

What the payments were for

  • Food & beverage$8,782100%
  • Entertainment$400%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,822 in reported general payments places this provider in the 70th percentile of 260 foot & ankle surgery providers in Virginia.

See all foot & ankle surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$186,521
Medicare patients
399
Services billed
3,250

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin94$2,107
Pregabalin86$1,840
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav70$787
Doxycycline Hyclate62$723
Ammonium Lactate22$675
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim47$383
Ciprofloxacin Hcl32$375
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip14$296
Terbinafine Hcl17$180
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$166
Duloxetine Hcl14$157
Clindamycin Hcl11$152
Ondansetron OdtOndansetron11$147
Meloxicam78$135
Levofloxacin11$99

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Roanoke

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →